Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2008
12/18/2008WO2008153027A1 Pyrroloquinoline derivative and use thereof
12/18/2008WO2008152423A2 Treatment of inflammation or autoimmune diseases with sulphated compounds
12/18/2008WO2008152421A2 Modification of cytokine levels with glucosylamine compounds
12/18/2008WO2008152226A2 Homogeneous and stable composition rich in oleaginous substances based on a milk product, method for the preparation thereof and uses thereof
12/18/2008WO2008152149A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
12/18/2008WO2008152142A1 2 -aminoquinazoline derivatives and their therapeutic uses
12/18/2008WO2008151434A1 Small cationic antimicrobial peptides
12/18/2008WO2008130879A3 Tetrahydroindole and tetrahydroindazole derivatives
12/18/2008WO2008130321A3 Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
12/18/2008WO2008130320A3 Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
12/18/2008WO2008129270A3 Compositions comprising anti-inflammatory compounds
12/18/2008WO2008124857A8 Plant extract, and use thereof
12/18/2008WO2008115974A3 Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
12/18/2008WO2008109380B1 Nucleic acid compounds for inhibiting vegfr family gene expression and uses thereof
12/18/2008WO2008100457A3 Functionally selective alpha2c adrenoreceptor agonists
12/18/2008WO2008094942A3 Humanized antibodies against cxcr3
12/18/2008WO2003024455A8 Stent coated with a sustained-release drug delivery and method for use thereof
12/18/2008US20080312449 New Compounds
12/18/2008US20080312421 Use of A33 antigens and JAM-it
12/18/2008US20080312417 Ucp5
12/18/2008US20080312323 Inhibition of TNF-alpha-Initiated Response
12/18/2008US20080312322 Organic Compounds
12/18/2008US20080312310 Compounds, Compositions and Methods
12/18/2008US20080312307 Mapk/erk kinase inhibitors
12/18/2008US20080312298 Methods for Identification of Modulators of Carm1 Methyl Transferase Activity
12/18/2008US20080312294 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4 beta ,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; glucocorticoid receptor modulators; antiinflammatory agents; Alzheimer's disease; side effect reduction
12/18/2008US20080312273 Quinoline Derivatives Having Vegf Inhibiting Activity
12/18/2008US20080312266 Steroidal Compounds For Inhibiting Steroid Sulphatase
12/18/2008US20080312259 SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
12/18/2008US20080312258 METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
12/18/2008US20080312233 Therapeutic Morpholino-Substituted Compounds
12/18/2008US20080312229 Organic Compounds
12/18/2008US20080312225 Triazolophthalazines
12/18/2008US20080312219 Biologically active methylene blue derivatives
12/18/2008US20080312217 N,N'-Bis-{4-[N'-(3,5-diamino-6-chloro-pyrazine-2-carbonyl)-guanidino]-butyl}terephthalamide, used for the treatment of conditions mediated by the blockade of an epithelial sodium channels
12/18/2008US20080312193 Substituted Tetracycline Compounds for Treatment of Inflammatory Skin Disorders
12/18/2008US20080311232 Cooling Compounds
12/18/2008US20080311212 Crystalline isoxazole derivative and pharmaceutical preparation thereof
12/18/2008US20080311201 Modified release solid or semi-solid dosage forms
12/18/2008US20080311188 Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol
12/18/2008US20080311171 Implantable polymeric device for sustained release of dopamine agonist
12/18/2008US20080311130 Integrin Alpha L I Domain Mutants with Increased Binding Affinity
12/18/2008US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof
12/18/2008US20080311116 Process for the Determination of Inflammatory Process and Pharmaceutical Compositions for the Treatment Thereof
12/18/2008US20080311111 Competitive Domain Antibody Formats That Bind Interleukin 1 Receptor Type 1
12/18/2008US20080311103 Anti-Inflammatory Peptides and Methods of Use Thereof
12/18/2008US20080311080 Bifidobacterium in the treatment of inflammatory disease
12/18/2008US20080311074 Inhibitors against activation of NF-kappaB
12/18/2008CA2693126A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
12/18/2008CA2690267A1 Small cationic antimicrobial peptides
12/18/2008CA2690124A1 C3b antibodies and methods for the prevention and treatment of complement-associated disorders
12/18/2008CA2686833A1 Compositions and methods for modulating inflammation using fluoroquinolones
12/18/2008CA2683313A1 Benefit agent containing delivery particle
12/17/2008EP2003203A1 Ligand for receptor activator of nf-kappa b, ligand is member of TNF superfamily
12/17/2008EP2002846A2 Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases
12/17/2008EP2002842A2 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
12/17/2008EP2002834A1 Aryl and hetaryl amides as modulators of EP2 receptors
12/17/2008EP2001886A2 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
12/17/2008EP2001864A1 Heterocyclic organic compounds for the treatment of in particular melanoma
12/17/2008EP2001851A2 Amide derivatives and their application for the treament of g protein related diseases
12/17/2008EP2001474A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/17/2008EP2001455A2 Methods of treating muscular wasting diseases using nf-kb activation inhibitors
12/17/2008EP1753736B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/17/2008EP1673360B1 Furan derivatives as ep4 receptor antagonists
12/17/2008EP1536778B1 Proteins binding to cross-beta structure comprising amyloid and methods for modulation of the cross-beta structure, its formation and its associated toxicity
12/17/2008EP1503759B1 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
12/17/2008EP1369119B1 Il-12 expression controlling agents
12/17/2008EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
12/17/2008EP1077943B1 Heterocyclic inhibitors of p38
12/17/2008EP0859603B1 Sustained release matrix for high-dose insoluble drugs
12/17/2008CN101326192A Novel dihydropseudoerythromycin derivatives
12/17/2008CN101326185A Aryl acetic acid and ester derivatives and their uses as antiinflammatory
12/17/2008CN101326183A Bicyclic heterocyclic compounds as antiinflammatory agents
12/17/2008CN101326169A Glucocorticoid receptor modulators as antiinflammatory agents
12/17/2008CN101326164A Inhibitors of CCR9 activity
12/17/2008CN101326162A Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
12/17/2008CN101326155A Propionamide compounds as antiinflammatory agents
12/17/2008CN101325965A Use of transferrins for treating destructive inflammation of mucous membrane
12/17/2008CN101325953A 4-heteroaryl-pyrimidine derivatives and use thereof as protein kinase inhibitors
12/17/2008CN101323648A Extraction method and and purification method of Sanghuang mushroom polysaccharide
12/17/2008CN101323604A Novel PPAR alpha/beta dual agonist, preparation and use thereof
12/17/2008CN101322828A Medicament for treating soft tissue scathing
12/17/2008CN101322823A Chinese medicine for dissipating cold, clearing heat, harmonizing nutrient and relieving pain and preparation thereof
12/17/2008CN101322817A Compound flavescent sophora root sustained-release dropping pill and preparation thereof
12/17/2008CN101322816A Chinese medicinal composition for treating scapulohumeral periarthritis and preparation thereof
12/17/2008CN101322810A Chinese traditional medicine composition for treating diabetes respiratory tract infection
12/17/2008CN101322805A Plaster for activating blood, resolving stasis, dispelling arthralgia spasm and easing pain, and preparation
12/17/2008CN101322796A Pain-easing plaster for protrusion of lumbar vertebral disc
12/17/2008CN101322789A Medicinal liquor prescription for treating rheumatism and rheumatoid
12/17/2008CN101322787A Specific medicinal liquor for treating rheumatoild disease
12/17/2008CN101322785A Prescription for treating rheumatism, rheumatoid arthrosis disease
12/17/2008CN101322776A Chinese medicinal composition for treating exogenous fever and preparation thereof
12/17/2008CN101322755A Medicament composition, external-use paste and preparation thereof
12/17/2008CN101322749A Chinese medicine oral liquid for treating wind-heat cold and preparation thereof
12/17/2008CN101322745A Medicament for treating inflammation
12/17/2008CN101322741A Chinese medicinal composition for treating periodontitis and preparation thereof
12/17/2008CN101322735A Optimizing method for attenuation processing of Tripterygium wilfordii and related formulation
12/17/2008CN101322734A Codonopsis lanceolata total saponins with antiinflammatory immunity function and preparation thereof
12/17/2008CN101322732A Method for processing asarum herb
12/17/2008CN101322729A Using method of Chinese chestnut kernel alcohol extract as antiinflammatory medicament
1 ... 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 ... 1272